Durvalumab and Consolidation SBRT Following Chemoradiation for Locally Advanced Stage III Non-Small Cell Lung

NCT03589547 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Stage III Non-small-cell Lung Cancer

Interventions

DRUG: Durvalumab
RADIATION: SBRT

Sponsor

Brown University

Collaborators

[object Object]